Ondansetron Tablet, Film Coated
Product Images NDC 68071-3801

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-3801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3801 1)

Pdp (68071 3801 1)
Ondansetron 8 mg tablets label from NuCare Pharmaceuticals, Inc. The film-coated tablets are packaged in a quantity of 10. The label includes product number P2147010, warnings to keep out of reach of children, and storage instructions at controlled temperature 68-77°F. It also lists the manufacturer as Aurobindo Pharma Limited, India, with dosing instructions to take 1 tablet every 8 hours.*
FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure diagram of ondansetron, showing the molecular arrangement including aromatic rings, nitrogen atoms, and methyl groups, consistent with the active ingredient in the medication Ondansetron.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.